# Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group

> **NCT03967834** · NA · RECRUITING · sponsor: **Institut Claudius Regaud** · enrollment: 400 (estimated)

## Conditions studied

- Soft Tissue Sarcoma
- Clear Cell Sarcoma
- Epithelioid Sarcoma
- Perivascular Epithelioid Cell Neoplasms
- Desmoplastic Small Round Cell Tumor
- Malignant Solitary Fibrous Tumors
- Alveolar Soft Part Sarcoma
- Epithelioid Hemangioendothelioma
- Low Grade Fibromyxoid Sarcoma
- Sclerosing Epithelioid Fibrosarcoma

## Interventions

- **OTHER:** Patient with Soft Tissue Sarcoma

## Key facts

- **NCT ID:** NCT03967834
- **Lead sponsor:** Institut Claudius Regaud
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-04-26
- **Primary completion:** 2031-04
- **Final completion:** 2031-04
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2026-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03967834

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03967834, "Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03967834. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*